Egivac

Egivac signed a memorandum of understanding with the Egyptian Ministry of Health to supply the ministry's annual needs of vaccines and sera for five years.

The Holding Company for Biological Products and Vaccines (VACSERA) started operating a new plant for sera and sterile filling at its subsidiary Egivac, built with investments of EGP 700 million. The plant has a capacity of 8.64 million ampoules and 4.32 million vials per month, producing 13 types of sera and vaccines.